12 results match your criteria: "Department of Internal Medicine Rush University Medical Center Chicago IL.[Affiliation]"

Attention to social justice is essential to improving cardiovascular health outcomes. In the absence of social justice, equitable cardiovascular health is impossible. This viewpoint provides a brief synopsis of the 2023 -sponsored session titled "Moving Towards Social Justice in Cardiovascular Health.

View Article and Find Full Text PDF

Background: Both cancer and cardiovascular disease (CVD) are the leading causes of death worldwide. Although our previous study detected a relationship between CVD and cancer incidence, limited evidence is available regarding the relationship between CVD, cardiovascular risk factors, and cancer mortality.

Methods And Results: A prospective cohort study using data from the continuous NHANES (National Health and Nutrition Examination Survey, 1999-2016) merged with Medicare and National Death Index mortality data, through December 31, 2018.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors (ICIs) have uncommon associations with cardiotoxicity, yet these cardiotoxic effects are associated with high mortality. An accurate assessment of risk for cardiotoxicity is essential for clinical decision-making, but data from randomized controlled trials often differ from real-world observational studies.

Methods And Results: A systematic search of PubMed, Embase, Cochrane Library, and Scopus was performed, including phase II and III randomized controlled trials (RCTs) and observational studies (OSs) reporting myocarditis or pericardial disease, myocardial infarction, or stroke with an immunotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • A study aimed to create a risk score for assessing cardiovascular risks in patients undergoing hematopoietic stem cell transplantation (HSCT) due to limited existing guidelines.
  • Using data from the CARE-BMT study, researchers analyzed various predictive factors related to cardiovascular events in over 2,400 HSCT patients, leading to the development of a point-based risk score.
  • This score categorizes patients into low, intermediate, and high-risk groups for cardiovascular issues post-transplant, potentially aiding in specialist referrals and long-term monitoring of high-risk individuals.
View Article and Find Full Text PDF

Background Women have higher circulating levels of soluble urokinase-type plasminogen activator receptor (suPAR), and elevated suPAR is associated with cardiovascular risk. The independent association of sex with suPAR and the impact of sex on its association with cardiovascular risk are unknown. Methods and Results Plasma suPAR was measured using ELISA in 2 cohorts of 666 asymptomatic individuals (49 years, 65% women) and 4184 patients with coronary artery disease (63 years, 37% women).

View Article and Find Full Text PDF